Literature DB >> 32700348

Case report of a fatal rectal haemorrhage in a person with severe haemophilia A receiving emicizumab and high-dose bypassing agents in the HAVEN 1 study.

Liane Khoo1, Stephen Matthews1, Geoffrey Kershaw1, Michael Pidcock2, Alex Phipps3, Anna Kiialainen4, Tiffany Chang5.   

Abstract

Entities:  

Year:  2020        PMID： 32700348     DOI： 10.1111/hae.14110

Source DB:  PubMed          Journal:  Haemophilia        ISSN： 1351-8216            Impact factor:   4.287


× No keyword cloud information.
  3 in total

1.  Long-term outcomes with emicizumab prophylaxis for hemophilia A with or without FVIII inhibitors from the HAVEN 1-4 studies.

Authors:  Michael U Callaghan; Claude Negrier; Ido Paz-Priel; Tiffany Chang; Sammy Chebon; Michaela Lehle; Johnny Mahlangu; Guy Young; Rebecca Kruse-Jarres; Maria Elisa Mancuso; Markus Niggli; Monet Howard; Nives Selak Bienz; Midori Shima; Victor Jiménez-Yuste; Christophe Schmitt; Elina Asikanius; Gallia G Levy; Steven W Pipe; Johannes Oldenburg
Journal:  Blood       Date:  2021-04-22       Impact factor: 22.113

2.  Establishment of a framework for assessing mortality in persons with congenital hemophilia A and its application to an adverse event reporting database.

Authors:  Steven W Pipe; Rebecca Kruse-Jarres; Johnny N Mahlangu; Glenn F Pierce; Flora Peyvandi; Peter Kuebler; Christian De Ford; Fabián Sanabria; Richard H Ko; Tiffany Chang; Charles R M Hay
Journal:  J Thromb Haemost       Date:  2021-01       Impact factor: 5.824

3.  Application of a hemophilia mortality framework to the Emicizumab Global Safety Database.

Authors:  Flora Peyvandi; Johnny N Mahlangu; Steven W Pipe; Charles R M Hay; Glenn F Pierce; Peter Kuebler; Rebecca Kruse-Jarres; Midori Shima
Journal:  J Thromb Haemost       Date:  2021-01       Impact factor: 5.824
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.